KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Receivables Refunds (2020 - 2022)

Historic Receivables Refunds for GoodRx Holdings (GDRX) over the last 3 years, with Q4 2022 value amounting to $4.5 million.

  • GoodRx Holdings' Receivables Refunds fell 4569.68% to $4.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $4.5 million, marking a year-over-year decrease of 4569.68%. This contributed to the annual value of $4.5 million for FY2022, which is 4569.68% down from last year.
  • Latest data reveals that GoodRx Holdings reported Receivables Refunds of $4.5 million as of Q4 2022, which was down 4569.68% from $2.2 million recorded in Q3 2022.
  • In the past 5 years, GoodRx Holdings' Receivables Refunds ranged from a high of $79.8 million in Q2 2021 and a low of $2.2 million during Q3 2022
  • Moreover, its 3-year median value for Receivables Refunds was $22.3 million (2021), whereas its average is $24.4 million.
  • Per our database at Business Quant, GoodRx Holdings' Receivables Refunds crashed by 309.47% in 2021 and then plummeted by 9223.51% in 2022.
  • GoodRx Holdings' Receivables Refunds (Quarter) stood at $28.6 million in 2020, then plummeted by 70.83% to $8.3 million in 2021, then tumbled by 45.7% to $4.5 million in 2022.
  • Its Receivables Refunds was $4.5 million in Q4 2022, compared to $2.2 million in Q3 2022 and $16.8 million in Q2 2022.